As cancer remains a leading cause of mortality globally, the demand for innovative oncology drugs continues to surge. The Oncology Drugs Market is projected to reach an impressive USD 763.21 billion by 2035, with a compound annual growth rate (CAGR) of 14.2% from 2024 onward. This substantial market growth highlights the necessity for advanced therapeutic strategies to combat various cancer...